Concepedia
Statistics
Publications
17
Citations
282
H-Index
12
Active since
1981
Affiliations
Horizon Therapeutics (United States)(Current)
University of Illinois Chicago
Illinois Bone and Joint Institute
Schlosspark-Klinik
Icahn School of Medicine at Mount Sinai
Robert J. Holt is an author at Horizon Therapeutics (United States) specializing in drug safety, osteoarthritis, and rheumatology.
Top concepts
MedicineDrug SafetyMicrobiologyPharmacologyRheumatologyOsteoarthritisPharmacotherapyPharmacoepidemiologyRheumatoid Arthritis
Publications per year
1981–2024
Efficacy and safety of diclofenac sodium 2% topical solution for osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled, 4 week study
Linda Wadsworth, Jeffrey D. Kent, Robert J. Holt · Current Medical Research and Opinion · 2015 · 42 citations · Full text
Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study
Megan Francis‐Sedlak, Brian LaMoreaux, Lissa Padnick‐Silver et al. · Rheumatology and Therapy · 2020 · 25 citations · Full text
Chemoprophylaxis of Recurrent Otitis Media Using Trimethoprim/Sulfamethoxazole
John D. Gaskins, Robert J. Holt, Catherine U. Kyong et al. · Drug Intelligence & Clinical Pharmacy · 1982 · 23 citations
Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis
Rieke Alten, Amy Grahn, Robert J. Holt et al. · RMD Open · 2015 · 21 citations · Full text
Hypoprothrombinemia Associated with Moxalactam Treatment of a Septic Sternoclavicular Arthritis Due to <i>Citrobacter Diversus</i>
Robert J. Holt, Martin Gorrochategui, Casilda Perez · Drug Intelligence & Clinical Pharmacy · 1981 · 20 citations
Moxalactam Treatment, Microbiology, Hypoprothrombinemia Associated
1–5 of 17